scispace - formally typeset
A

Alexey Schramko

Researcher at University of Helsinki

Publications -  39
Citations -  761

Alexey Schramko is an academic researcher from University of Helsinki. The author has contributed to research in topics: Thromboelastometry & Cardiopulmonary bypass. The author has an hindex of 14, co-authored 38 publications receiving 628 citations. Previous affiliations of Alexey Schramko include Helsinki University Central Hospital.

Papers
More filters
Journal ArticleDOI

Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy

TL;DR: Human fibrinogen concentrate was associated with increased allogeneic blood product transfusion, an unexpected finding contrary to previous studies, and may not be effective in this setting when administered according to 5-minute bleeding mass.
Journal ArticleDOI

Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial

TL;DR: It is concluded that a short-time infusion of rapidly degradable HES solutions after cardiac surgery produces impairment in fibrin formation and clot strength in thromboelastometry tracings.
Journal ArticleDOI

Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial

TL;DR: Even a small dose of HES 130/0.4 or gelatin impaired clot strength after cardiac surgery in a dose-dependent fashion, but neither colloid increased blood loss.
Journal ArticleDOI

Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution.

TL;DR: The purpose of this study was to evaluate the capacity of single coagulation factors to reverse gelatin‐promoted whole‐blood coagulating disorders in vitro.
Journal ArticleDOI

Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin.

TL;DR: The effect of albumin on cardiac performance is inferior than that of HES130 or HES200 in early postoperative phase after cardiac surgery in a prospective, randomized, open-label study.